Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck Completes Acquisition of Terns Pharmaceuticals
Wednesday, May 06, 2026Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals
ZETA SURGICAL® Receives FDA 510(k) Clearance Expanding Access to Brain Tumor Biopsies, Hydrocephalus, and Trigeminal Neuralgia
Tuesday, May 05, 2026Arrowhead Pharmaceuticals Inc has announced that Australias Therapeutic Goods Administration TGA has approved REDEMPLO plozasiran The medicine is a small interfering RNA siRNA therapy used alongside
CS Analytical Announces Major Laboratory Expansion
Tuesday, May 05, 2026CS Analytical Laboratory has announced plans to expand its facility in Clifton New Jersey by doubling its current laboratory space The company is a cGMPcompliant FDAregistered and inspected contract laboratory focused on package and container
TLX101-Px (Pixlumi®) MAA Accepted in Europe
Saturday, May 02, 2026Telix Pharmaceuticals has announced that its marketing authorisation application MAA for TLXPx Pixlumi a brain cancer imaging candidate has been validated and accepted for review in Europe
TRUQAP recommended by FDA advisory panel for PTEN-deficient prostate cancer
Friday, May 01, 2026US Food and Drug Administrations Oncologic Drugs Advisory Committee has supported the use of TRUQAP capivasertib in combination with abiraterone and androgen deprivation therapy ADT for patients
Evotec secures grants to advance tuberculosis treatment
Thursday, April 30, 2026Evotec SE has secured two new grants from the Bill Melinda Gates Foundation to support drug discovery and translational research in tuberculosis TB This follows four earlier TB grants from the foundation valued at million over months and million...
Huahui Health signs global agreement with BeOne Medicines for oncology drug HH160
Thursday, April 30, 2026Huahui Health has entered into a global exclusive option licence and collaboration agreement with BeOne Medicines for HH a novel trispecific antibody designed for cancer immunotherapy The agreement grants BeOne Medicines an exclusive option to develo...
Remepy Partners with Merck to Develop Hybrid Drugs Across Therapeutic Areas
Wednesday, April 29, 2026Remepy has entered into a collaboration with Merck to advance the development of hybrid drugs across multiple therapeutic areashe initial phase of the partnership will focus on selected programmes in the United States particularly in a rare tumour se...
Gilead Acquires Arcellx to Strengthen Cancer Treatment Pipeline
Wednesday, April 29, 2026Gilead Sciences has completed its acquisition of Arcellx in a deal valued at approximately billion Anitocel is a BCMAdirected CAR Tcell therapy that uses a Ddomain binder This design aims to improve CAR expression while reducing unwanted immune acti...
Taiho Oncology Announces FDA Acceptance of Zipalertinib Application for Advanced Lung Cancer
Wednesday, April 29, 2026Taiho Oncology along with Taiho Pharmaceutical and Cullinan Therapeutics has announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for zipalertinib
